{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:25:48Z","timestamp":1740147948527,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12149-019-01406-0","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T07:05:56Z","timestamp":1570777556000},"page":"930-936","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential prognostic implications of myocardial thallium-201 and iodine-123-beta-methylpentadecanoic acid dual scintigraphy in patients with Anderson\u2013Fabry disease"],"prefix":"10.1007","volume":"33","author":[{"given":"Tomoaki","family":"Haga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5076-2052","authenticated-orcid":false,"given":"Takahiro","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuji","family":"Somura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoaki","family":"Kano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasuku","family":"Kuwayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Hiraiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Sawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,11]]},"reference":[{"key":"1406_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJM199508033330504","volume":"333","author":"S Nakao","year":"1995","unstructured":"Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, et al. An atypical variant of Fabry\u2019s disease in men with left ventricular hypertrophy. N Engl J Med. 1995;333:288\u201393.","journal-title":"N Engl J Med"},{"key":"1406_CR2","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/jmg.38.11.750","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet. 2001;38:750\u201360.","journal-title":"J Med Genet"},{"key":"1406_CR3","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jjcc.2016.05.014","volume":"69","author":"T Kubo","year":"2017","unstructured":"Kubo T, Ochi Y, Baba Y, Hirota T, Tanioka K, Yamasaki N, et al. Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy. J Cardiol. 2017;69:302\u20137.","journal-title":"J Cardiol"},{"key":"1406_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.pcad.2009.11.002","volume":"52","author":"C O\u2019Mahony","year":"2010","unstructured":"O\u2019Mahony C, Elliot P. Anderson-Fabry disease and the heart. Prog Cardiovasc Dis. 2010;52:326\u201335.","journal-title":"Prog Cardiovasc Dis"},{"key":"1406_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/hrt.2006.104026","volume":"94","author":"DA Hughes","year":"2008","unstructured":"Hughes DA, Elliot PM, Shah J, Zuckerman J, Coghlan G, Brookes J, et al. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomized, double-blind, placebo-controlled clinical trial of agalsidase alfa. Heart. 2008;94:153\u20138.","journal-title":"Heart"},{"key":"1406_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jjcc.2007.12.001","volume":"51","author":"T Takenaka","year":"2008","unstructured":"Takenaka T, Teraguchi H, Yoshida A, Taguchi S, Ninomiya K, Umekita Y, et al. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study. J Cardiol. 2008;51:50\u20139.","journal-title":"J Cardiol"},{"key":"1406_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0033-0620(72)90029-1","volume":"3","author":"JR Neely","year":"1972","unstructured":"Neely JR, Rovetto MJ, Oram JF. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis. 1972;3:289\u201332929.","journal-title":"Prog Cardiovasc Dis"},{"key":"1406_CR8","first-page":"1529","volume":"34","author":"S Wakasugi","year":"1993","unstructured":"Wakasugi S, Fischman AJ, Babich JW, Callahan RJ, Elmaleh DR, Wilkinson R, et al. Myocardial substrate utilization and left ventricular function in Adriamycin cardiomyopathy. J Nucl Med. 1993;34:1529\u201335.","journal-title":"J Nucl Med"},{"key":"1406_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1071-3581(98)90129-5","volume":"5","author":"H Narus","year":"1998","unstructured":"Narus H, Arii T, Kondo T, Morita M, Ohyanagi M, Iwasaki T, et al. Fatty acid imaging of stunned myocardium: clinical usefulness of iodine 123-labeled fatty acid imaging in patients with acute myocardial infarction. J Nucl Cardiol. 1998;5:275\u201384.","journal-title":"J Nucl Cardiol"},{"key":"1406_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000007001","volume":"93","author":"M Shimizu","year":"2000","unstructured":"Shimizu M, Ino H, Okeie K, Emoto Y, Yamaguchi M, Yasuda T, et al. Cardiac dysfunction and long-term prognosis in patients with nonobstructive hypertrophic cardiomyopathy and abnormal 123I\u201315 (p-iodophenyl)-3 (R, S) -methylpentadecanoic acid myocardial scintigraphy. Cardiology. 2000;93:43\u20139.","journal-title":"Cardiology"},{"key":"1406_CR11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/BF03006666","volume":"17","author":"C Zhao","year":"2003","unstructured":"Zhao C, Shuke N, Okizaki A, Yamamoto W, Sato J, Ishikawa Y, et al. Comparison of myocardial fatty acid metabolism with left ventricular function and perfusion in cariomyopathies: by 123I-BMIPP SPECT and 99mTc-tetrofosmin electrocardiographically gated SPECT. Ann Nucl Med. 2003;17:541\u20138.","journal-title":"Ann Nucl Med"},{"key":"1406_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12149-007-0045-8","volume":"21","author":"A Inoue","year":"2007","unstructured":"Inoue A, Fujimoto S, Yamashina S, Yamazaki J. Prediction of cardiac events in patients with dilated cardiomyopathy using 123I-BMIPP and 201Tl myocardial scintigraphy. Ann Nucl Med. 2007;21:399\u2013404.","journal-title":"Ann Nucl Med"},{"key":"1406_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12149-016-1064-0","volume":"30","author":"KV Zavadovsky","year":"2016","unstructured":"Zavadovsky KV, Gulya MO, Lishmanov YB, Levedev DI. Perfusion and metabolic scintigraphy with 123I-BMIPP in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy. Ann Nucl Med. 2016;30:325\u201333.","journal-title":"Ann Nucl Med"},{"key":"1406_CR14","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1007\/s00259-004-1556-3","volume":"31","author":"M Nanasato","year":"2016","unstructured":"Nanasato M, Hirayama H, Ando A, Isobe S, Nonokawa M, Kinoshita Y, et al. Incremental predictive value of myocardial scintigraphy with 123I-BMIPP in patients with acute myocardial infarction treated with primary percutaneous coronary intervention. Eur J Nucl Med Mol Imaging. 2016;31:1512\u201321.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1406_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/BF00837625","volume":"23","author":"N Tamaki","year":"1996","unstructured":"Tamaki N, Tadamura E, Kudoh T, Hattori N, Yonekura Y, Nohara R, et al. Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction. Eur J Nucl Med. 1996;23:272\u20139.","journal-title":"Eur J Nucl Med"},{"key":"1406_CR16","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1161\/CIRCULATIONAHA.114.012178","volume":"130","author":"A Frustaci","year":"2014","unstructured":"Frustaci A, Russo MA, Francone M, Chimenti C. Microvascular angina as prehypertrophic presentation of Fabry disease cardiomyopathy. Circulation. 2014;130:1530\u20131.","journal-title":"Circulation"},{"key":"1406_CR17","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"YA Zarate","year":"2008","unstructured":"Zarate YA, Hopkin RJ. Lysosomal strage disease 3. Fabry\u2019s disease. Lancet. 2008;372:1427\u201335.","journal-title":"Lancet"},{"issue":"1","key":"1406_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12350-008-9018-0","volume":"16","author":"DS Berman","year":"2009","unstructured":"Berman DS, Kang X, Gransar H, Gerlach J, Friedman JD, Hayes SW, et al. Quantitative assessment of myocardial perfusion abnormality on SPECT myocardial perfusion imaging is more reproducible than expert visual analysis. J Nucl Cardiol. 2009;16(1):45\u201353.","journal-title":"J Nucl Cardiol"},{"key":"1406_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Luigi PB, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr. 2015;28:1\u201339.","journal-title":"J Am Soc Echocardiogr"},{"key":"1406_CR20","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00259-015-3273-5","volume":"43","author":"L Spinelli","year":"2016","unstructured":"Spinelli L, Pellegrino T, Pisani A, Giudice CA, Riccio E, Imbriaco M, et al. Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by 123I-meta-iodobenzylguanidine imaging in Anderson-Fabry disease. Eur J Nucl Med Mol Imaging. 2016;43:729\u201339.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1406_CR21","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1007\/s00259-017-3778-1","volume":"44","author":"M Imbriaco","year":"2017","unstructured":"Imbriaco M, Pellegrino T, Piscopo V, Petretta M, Ponsiglione A, Nappi C, et al. Cardiac sympathetic neuronal damage precedes myocardial fibrosis in patients with Anderson-Fabry disease. Eur J Nucl Med Mol Imaging. 2017;44:2266\u201373.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1406_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jacc.2007.08.057","volume":"51","author":"M Nishimura","year":"2008","unstructured":"Nishimura M, Tsukamoto K, Hasebe N, Tamaki N, Kikuchi K, Ono T. Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging. J Am Coll Cardiol. 2008;51:139\u201345.","journal-title":"J Am Coll Cardiol"},{"key":"1406_CR23","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/ki.1994.182","volume":"45","author":"M Barenbrock","year":"1994","unstructured":"Barenbrock M, Spieker C, Laske V, Heidenreich S, Hohage H, Bachmann J, et al. Studies of the vessel wall properties in hemodialysis patients. Kidney Int. 1994;45:1397\u2013400.","journal-title":"Kidney Int"},{"key":"1406_CR24","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1681\/ASN.V961018","volume":"9","author":"K Amman","year":"1998","unstructured":"Amman K, Breitbach M, Ritz E, Mall G. Myocyte\/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol. 1998;9:1018\u201322.","journal-title":"J Am Soc Nephrol"},{"key":"1406_CR25","first-page":"1934","volume":"36","author":"K Nakajima","year":"1995","unstructured":"Nakajima K, Shimizu K, Taki J, Uetani Y, Konishi S, Tonami N, et al. Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina. J Nucl Med. 1995;36:1934\u201340.","journal-title":"J Nucl Med"},{"key":"1406_CR26","first-page":"1407","volume":"38","author":"Y Takeishi","year":"1997","unstructured":"Takeishi Y, Fujiwara S, Atsumi H, Takahashi K, Sukekawa H, Tomoike H. Iodine-123-BMIPP imaging in unstable angina: a guide for interventional strategy. J Nucl Med. 1997;38:1407\u201311.","journal-title":"J Nucl Med"},{"key":"1406_CR27","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/S0735-1097(01)01634-5","volume":"38","author":"Y Kawai","year":"2001","unstructured":"Kawai Y, Tsukamoto E, Nozaki T, Morita K, Sakurai M, Tamaki N. Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol. 2001;38:1888\u2013944.","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"1406_CR28","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","volume":"24","author":"JC Moon","year":"2003","unstructured":"Moon JC, Sachdev B, Elkington AG, McKenna WJ, Mehta A, Pennell DJ, et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Eur Heart J. 2003;24(23):2151\u20135.","journal-title":"Eur Heart J"},{"key":"1406_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12149-009-0337-2","volume":"24","author":"K Nakajima","year":"2010","unstructured":"Nakajima K. Normal values for nuclear cardiology: Japanese databases for myocardial perfusion, fatty acid and sympathetic imaging and left ventricular function. Ann Nucl Med. 2010;24:125\u201335.","journal-title":"Ann Nucl Med"},{"key":"1406_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12149-016-1065-z","volume":"30","author":"K Nakajima","year":"2016","unstructured":"Nakajima K, Matsumoto N, Kasai T, Matsuo S, Kiso K, Okuda K. Normal values standardization of parameters in nuclear cardiology: Japanese Society of Nuclear Medicine working group database. Ann Nucl Med. 2016;30:188\u201399.","journal-title":"Ann Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-019-01406-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-019-01406-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-019-01406-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T11:44:41Z","timestamp":1664624681000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-019-01406-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1406"],"URL":"https:\/\/doi.org\/10.1007\/s12149-019-01406-0","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"type":"print","value":"0914-7187"},{"type":"electronic","value":"1864-6433"}],"subject":[],"published":{"date-parts":[[2019,10,11]]},"assertion":[{"value":"16 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"T.O. received lecture fees from Ono Yakuhin, Medtronics, and Otsuka, and research grants from Ono Yakuhin, Bayer, Daiichi-Sankyo, and Amgen Astellas, not in connection with the submitted work. S.I. received lecture fee from FUJIFILM RI Pharma and Nihon Medi-Physics. T.M. received lecture fees and unrestricted research grants for the Department of Cardiology, Nagoya University Graduate School of Medicine, from Bayer, Daiichi-Sankyo, Dainippon Sumitomo, Kowa, MSD, Mitsubishi Tanabe, Boehringer Ingelheim, Novartis, Pfizer, Sanofi-Aventis, Takeda, Astellas, Otsuka, and Teijin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}